Stock Price
24.25
Daily Change
-0.92 -3.66%
Monthly
-5.27%
Yearly
1.08%
Q1 Forecast
23.84

Celldex Therapeutics reported $-73.62M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AbbVie USD 4.58B 1.13B Sep/2025
Amgen USD 3.96B 464M Dec/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Celldex Therapeutics USD -73.62M 9.76M Sep/2025
Glaxosmithkline GBP 3.76B 1.32B Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025